Minireview: Host defence in invasive aspergillosis

Mycoses

Volumn 56, Issue 4, 2013, Pages 403-413

  Lass Flörl, Cornelia ^a   Roilides, Emmanuel ^b   Löffler, Jürgen ^c   Wilflingseder, Doris ^a   Romani, Luigina ^d  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Antifungal resistance; Innate immunity; Invasive aspergillosis

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4;

ADAPTIVE IMMUNITY; ANTIFUNGAL RESISTANCE; ARTICLE; ASPERGILLUS; EFFECTOR CELL; EPITHELIUM CELL; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; INVASIVE ASPERGILLOSIS; LEUKOCYTE; NATURAL KILLER CELL; PRIORITY JOURNAL; RECOGNITION; T LYMPHOCYTE; THROMBOCYTE;

ADAPTIVE IMMUNITY; ASPERGILLUS; HUMANS; IMMUNITY, INNATE; INVASIVE PULMONARY ASPERGILLOSIS; TH1 CELLS; TH2 CELLS;

ASPERGILLUS; FUNGI;

EID: 84879213352     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/myc.12052     Document Type: Article

References (104)

1. Park SJ, Mehrad B. Innate immunity to Aspergillus species. Clin Microbiol Rev 2009; 22: 535-51.
2. Roilides E, Simitsopoulou M. Local innate host response and filamentous fungi in patients with cystic fibrosis. Med Mycol 2010; 48: S22-31.
3. Denning DW. Invasive aspergillosis. Clin Infect Dis 1998; 26: 781-803.
4. Kliasova GA, Petrova NA, Parovichnikova EN et al. Invasive pulmonary aspergillosis. Ter Arkh J 2005; 7: 65-71.
5. Marr KA, Carter RA, Boeckh M, Martin P, Corey L. Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood 2002; 100: 4358-66.
6. Mikulska M, Raiola AM, Bruno B et al. Risk factors for invasive aspergillosis and related mortality in recipients of allogeneic SCT from alternative donors: an analysis of 306 patients. Bone Marrow Transplant 2009; 44: 361-70.
7. Pagano L, Girmenia C, Mele L et al. Infections caused by filamentous fungi in patients with hematologic malignancies. A report of 391 cases by GIMEMA Infection Program. Haematol 2001; 86: 862-70.
8. Post MJ, Lass-Floerl C, Gastl G, Nachbaur D. Invasive fungal infections in allogeneic and autologous stem cell transplant recipients: a single-center study of 166 transplanted patients. Transpl Infect Dis 2007; 9: 189-95.
9. Wiederhold NP, Lewis RE, Kontoyiannis DP. Invasive aspergillosis in patients with hematologic malignancies. Pharmacotherapy 2003; 23: 1592-610.
10. Lin SJ, Schranz J, Teutsch SM. Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis 2001; 32: 358-66.
11. Medzhitov R, Janeway CA Jr. Innate immunity: the virtues of a nonclonal system of recognition. Cell 1997; 91: 295-8.
12. Romani L. Immunity to fungal infections. Nature Rev 2011; 11: 275-88.
13. + T-cell responses to Aspergillus fumigatus in hematopoietic transplanted patients. Blood 2012; 119: 967-77.
14. + T cell vaccination overcomes defective cross-presentation of fungal antigens in a mouse model of chronic granulomatous disease. J Clin Invest 2012; 122: 1816-31.
15. Paris S, Debeaupuis JP, Crameri R et al. Conidial hydrophobins of Aspergillus fumigatus. Appl Environ Microbiol 2003; 69: 1581-8.
16. Tronchin G, Bouchara JP, Ferron M, Larcher G, Chabassee D. Cell surface properties of Aspergillus fumigatus conidia: correlation between adherence, agglutination, and rearrangements of the cell wall. Can J Microbiol 1995; 47: 714-21.
17. Latgé JP, Mouyna I, Tekaia F, Beauvais A, Debeaupuis JP, Niermann W. Specific molecular features in the organization and biosynthesis of the cell wall of Aspergillus fumigatus. Med Mycol 2005; 43: S15-22.
18. Gersuk GM, Underhill DM, Zhu L, Marr KA. Dectin-1 and TLRs permit macrophages to distinguish between different Aspergillus fumigatus cellular states. J Immunol 2006; 176: 3717-24.
19. Hohl TM, Van Epps HL, Rivera A et al. Aspergillus fumigatus triggers inflammatory responses by stage-specific beta-glucan display. PLoS Pathog 2005; 1: e30.
20. Steele C, Rapaka RR, Metz A et al. The beta-glucan receptor dectin-1 recognizes specific morphologies of Aspergillus fumigatus. PLoS Pathog 2005; 1: e42.
21. + -T-cell responses to live and heat-inactivated Aspergillus fumigatus conidia. Infect Immun 2005; 73: 7170-9.
22. Taylor PR, Tsoni SV, Willment JA et al. Dectin-1 is required for beta-glucan recognition and control of fungal infection. Nature Immunol 2007; 8: 31-8.
23. Werner JL, Metz AE, Horn D et al. Requisite role for the dectin-1 beta-glucan receptor in pulmonary defense against Aspergillus fumigatus. J Immunol 2009; 182: 4938-46.
24. Sturtevant J, Latge JP. Participation of complement in the phagocytosis of the conidia of Aspergillus fumigatus by human polymorphonuclear cells. J Infect Dis 1992; 16: 580-6.
25. Sturtevant JE, Latge JP. Interactions between conidia of Aspergillus fumigatus and human complement component C3. Infect Immun 1992; 60: 1913-8.
26. Behnsen J, Hartmann A, Schmaler J et al. The opportunistic human pathogenic fungus Aspergillus fumigatus evades the host complement system. Infect Immun 2008; 76: 820-7.
27. Vogl G, Lesiak I, Jensen DB et al. Immune evasion by acquisition of complement inhibitors: the mould Aspergillus binds both factor H and C4b binding protein. Mol Immunol 2008; 45: 1485-93.
28. Washburn RG, DeHart DJ, Agwu DE, Bryant-Varela BJ, Julian NC. Aspergillus fumigatus complement inhibitor: production, characterization, and purification by hydrophobic interaction and thin-layer chromatography. Infect Immun 1990; 58: 3508-15.
29. Washburn RG, Hammer CH, Bennett JE. Inhibition of complement by culture supernatants of Aspergillus fumigatus. J Infect Dis 1986; 154: 944-51.
30. Bottazzi B, Garlanda C, Cotena A et al. The long pentraxin PTX3 as a prototypic humoral pattern recognition receptor: interplay with cellular innate immunity. Immunol Rev 2009; 227: 9-18.
31. Garlanda C, Hirsch E, Bozza S et al. Non-redundant role of the long pentraxin PT3 in anti-fungal innate immune response. Nature 2002; 420: 182-6.
32. Dagenais TRT, Keller NP. Pathogenesis of Aspergillus fumigatus in invasive Aspergillosis. Clin Microbiol Rev 2009; 22: 447-65.
33. Schaffner A, Douglas H, Braude A. Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus. Observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes. J Clin Invest 1982; 69: 617-31.
34. Rossi D, Zlotnik A. The biology of chemokines and their receptors. Ann Rev Immunol 2000; 18: 217-42.
35. Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 2000; 12: 121-7.
36. Traynor TR, Huffnagle GB. Role of chemokines in fungal infections. Med Mycol 2001; 39: 41-50.
37. McCormick AL, Heesemann L, Wagener J et al. NETs formed by human neutrophils inhibit growth of the pathogenic mold Aspergillus fumigatus. Microbes Infect 2010; 12: 928-36.
38. Bruns S, Kniemeyer O, Hasenberg M et al. Production of extracellular traps against Aspergillus fumigatus in vitro and in infected lung tissue is dependent on invading neutrophils and influenced by hydrophobin RodA. PLoS Pathogen 2010; 6: e1000873.
39. Levitz SM, Farrell TP. Human neutrophil degranulation stimulated by Aspergillus fumigatus. J Leukoc Biol 1990; 47: 170-5.
40. Latge JP. Aspergillus fumigatus and Aspergillosis. Clin Microbiol Rev 1999; 12: 310-50.
41. Roilides E, Holmes A, Blake C et al. Antifungal activity of elutriated human monocytes against Aspergillus fumigatus hyphae: enhancement by granulocyte-macrophage colony-stimulating factor and interferon-γ. J Infect Dis 1994; 170: 894-9.
42. Diamond RD, Huber E, Haudenschild CC. Mechanisms of destruction of Aspergillus fumigatus hyphae mediated by human monocytes. J Infect Dis 1983; 147: 474-83.
43. Roilides EST, Holmes A et al. Effects of macrophage colony-stimulating factor on antifungal activity of mononuclear phagocytes against Aspergillus fumigatus. J Infect Dis 1995; 172: 1028-34.
44. Simitsopoulou M, Roilides E, Paliogianni F et al. Immunomodulatory effects of voriconazole on monocytes challenged with Aspergillus fumigatus: differential role of Toll-like receptors. Antimicrob Agents Chemother 2008; 52: 3301-6.
45. + blood monocytes: their role in infection and inflammation. J Leukoc Biol 2007; 81: 584-92.
46. Hohl TM, Rivera A, Lipuma L et al. Inflammatory monocytes facilitate adaptive CD4 T cell responses during respiratory fungal infection. Cell Host Microbe 2009; 6: 470-81.
47. Schaffner A, Douglas H, Braude AI, Davis CE. Killing of Aspergillus spores depends on the anatomical source of the macrophage. Infect Immun 1983; 41: 1109-15.
48. Waldorf AR, Levitz SM, Diamond RD. In vivo bronchoalveolar macrophage defense against Rhizopus oryzae and Aspergillus fumigatus. J Infect Dis 1984; 150: 752-60.
49. Levitz SM, Selsted ME, Ganz T et al. In vitro killing of spores and hyphae of Aspergillus fumigatus and Rhizopus oryzae by rabbit neutrophil cationic peptides and bronchoalveolar macrophages. J Infect Dis 1986; 154: 483-9.
50. Philippe B, Ibrahim-Granet O, Prevost MC et al. Killing of Aspergillus fumigatus by alveolar macrophages is mediated by reactive oxidant intermediates. Infect Immun 2003; 71: 3034-42.
51. Ibrahim-Granet O, Philippe B, Boleti H et al. Phagocytosis and intracellular fate of Aspergillus fumigatus conidia in alveolar macrophages. Infect Immun 2003; 71: 891-903.
52. Roilides E, Robinson T, Sein T, Pizzo PA, Walsh TJ. In vitro and ex vivo effects of cyclosporin A on phagocytic host defenses against Aspergillus fumigatus. Antimicrob Agents Chemother 1994; 38: 2883-8.
53. Berenguer J, Allende MC, Lee JW et al. Pathogenesis of pulmonary aspergillosis. Granulocytopenia versus cyclosporine and methylprednisolone-induced immunosuppression. Am J Respir Crit Care Med 1995; 152: 1079-86.
54. Akira S, Takeda K, Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nature Immunol 2001; 2: 675-80.
55. Braedel S, Radsak M, Einsele H et al. Aspergillus fumigatus antigens activate innate immune cells via toll-like receptors 2 and 4. Brit J Haematol 2004; 125: 392-9.
56. Netea MG, Warris A, Van der Meer JW et al. Aspergillus fumigatus evades immune recognition during germination through loss of toll-like receptor-4-mediated signal transduction. J Infect Dis 2003; 188: 320-6.
57. Mehrad B, Strieter RM, Standiford TJ. Role of TNF-alpha in pulmonary host defense in murine invasive aspergillosis. J Immunol 1999; 162: 1633-40.
58. Mambula SS, Sau K, Henneke P et al. Toll-like receptor (TLR) signaling in sresponse to Aspergillus fumigatus. J Biol Chem 2002; 277: 39320-6.
59. Levitz SM. Interactions of Toll-like receptors with fungi. Microbes Infect 2004; 6: 1351-5.
60. Brummer E, Kamberi M, Stevens DA. Regulation by granulocyte-macrophage colony-stimulating factor and/or steroids given in vivo of proinflammatory cytokine and chemokine production by bronchoalveolar macrophages in response to Aspergillus conidia. J Infect Dis 2003; 187: 705-9.
61. Mehrad B, Standiford TJ. Role of cytokines in pulmonary antimicrobial host defense. Immunol Res 1999; 20: 15-27.
62. Roilides E, Dimitriadou-Georgiadou A, Sein T, Kadiltsoglou I, Walsh TJ. Tumor necrosis factor alpha enhances antifungal activities of polymorphonuclear and mononuclear phagocytes against Aspergillus fumigatus. Infect Immun 1998; 66: 5999-6003.
63. Roilides E, Tsaparidou S, Kadiltsoglou I, Sein T, Walsh TJ. Interleukin-12 enhances antifungal activity of human mononuclear phagocytes against Aspergillus fumigatus: implications for a gamma interferon-independent pathway. Infect Immun 1999; 67: 3047-50.
64. Rodriguez-Adrian LJ, Grazzintti ML, Rex JH, Anaissie EJ. The potential role of cytokine therapy for fungal infections in patients with cancer: is recovery from neutropenia all that is needed?Clin Infect Dis 1998; 26: 1270-8.
65. Walsh TJ, Roilides E, Cortez K et al. Control, immunoregulation, and expression of innate pulmonary host defenses against Aspergillus fumigatus. Med Mycol 2005; 43: S165-7.
66. Gonzalez CE, Lyman CA, Lee S et al. Recombinant human macrophage colony-stimulating factor augments pulmonary host defences against Aspergillus fumigatus. Cytokine 2001; 15: 87-95.
67. Phadke AP, Mehrad B. Cytokines in host defense against Aspergillus: recent advances. Med Mycol 2005; 43: S173-6.
68. Cenci E, Mencacci A, Del Sero G et al. Interleukin-4 causes susceptibility to invasive pulmonary aspergillosis through suppression of protective type I responses. J Infect Dis 1999; 180: 1957-68.
69. Winn RM, Gil-Lamaignere C, Roilides E et al. Selective effects of interleukin (IL)-15 on antifungal activity and IL-8 release by polymorphonuclear leukocytes in response to hyphae of Aspergillus species. J Infect Dis 2003; 188: 585-90.
70. Cenci E, Perito S, Enssle KH et al. Th1 and Th2 cytokines in mice with invasive aspergillosis. Infect Immun 1997; 65: 564-70.
71. Roilides E, Dimitriadou A, Kadiltsoglou I et al. IL-10 exerts suppressive and enhancing effects on antifungal activity of mononuclear phagocytes against Aspergillus fumigatus. J Immunol 1997; 158: 322-9.
72. Botterel F, Gross K, Ibrahim-Granet O et al. Phagocytosis of Aspergillus fumigatus conidia by primary nasal epithelial cells in vitro. BMC Microbiol 2008; 8: 97.
73. Hope WW, Kruhlak MJ, Lyman CA et al. Pathogenesis of Aspergillus fumigatus and the kinetics of galactomannan in an in vitro model of early invasive pulmonary aspergillosis: implications for antifungal therapy. J Infect Dis 2007; 195: 455-66.
74. Zhang Z, Liu R, Noordhoek JA et al. Interaction of airway epithelial cells (A549) with spores and mycelium of Aspergillus fumigatus. J Infect 2005; 51: 375-82.
75. Balloy V, Sallenave JM, Wu Y et al. Aspergillus fumigatus-induced interleukin-8 synthesis y respiratory epithelial cells is controlled by the phosphatidylinositol 3-kinase, p38 MAPK, and ERK1/2 pathways and not by the Toll-like receptor-MyD88 pathway. J Biol Chem 2008; 283: 30513-21.
76. De Luca A, Bozza S, Zelante T et al. Non-hematopoietic cells contribute to protective tolerance to Aspergillus fumigatus via a TRIF pathway converging on IDO. Cell Mol Immunol 2010; 7: 459-70.
77. + T cells during Aspergillus fumigatus antigen exposure. Am J Respir Cell Mol Biol 2011; 44: 11-23.
78. Kiessling R, Klein E, Pross H, Wigzell H. Natural killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell. Eur J Immunol 1975; 5: 117-21.
79. Kiessling R, Klein E, Wigzell H. Natural killer cells in the mouse. I, Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur J Immunol 1975; 5: 112-5.
80. Gregoire C, Chasson L, Luci C et al. The trafficking of natural killer cells. Immunol Rev 2007; 220: 169-82.
81. Reynolds CW, Timonen T, Herbermann RB. Natural killer (NK) cell activity in the rat. I. Isolation and characterization of the effector cells. J Immunol 1981; 127: 282-7.
82. Basse PH, Hokland P, Gundersen HJ, Hokland M. Enumeration of organ-associated natural killer cells in mice: application of a new stereological method. APMIS 1992; 100: 202-8.
83. Stein-Streilein J, Bennett M, Mann D, Kumar V. Natural killer cells in mouse lung: surface phenotype, target preference, and response to local influenza virus infection. J Immunol 1983; 131: 2699-704.
84. Weissler JC, Nicod LP, Lipscomb MP, Toews GB. Natural killer cell function in human lung is compartmentalized. Am Rev Respir Dis 1987; 135: 941-9.
85. Morrison BE, Park SJ, Mooney JM, Mehrad B. Chemokine-mediated recruitment of NK cells is a critical host defense mechanism in invasive aspergillosis. J Clin Invest 2003; 112: 1862-70.
86. Park SJ, Hughes MA, Burdick M et al. Early NK cell-derived IFN-γ is essential to host defense in neutropenic invasive aspergillosis. J Immunol 2009; 182: 4306-12.
87. Bouzani M, Ok M, McCormick A et al. Human NK cells display important antifungal activity against Aspergillus fumigatus, which is directly mediated by IFN-γ release. J Immunol 2011; 187: 1369-76.
88. Schmidt S, Tramsen L, Hanisch M et al. Human natural killer cells exhibit direct activity agaist Aspergillus fumigatus hyphae, but not against resting conidia. J Infect Dis 2011; 203: 430-5.
89. Christin L, Wysong R, Meshulam T et al. Human platelets damage Aspergillus fumigatus hyphae and may supplement killing by neutrophils. Infect Immun 1998; 66: 1181-9.
90. Perkhofer S, Kehrel BE, Dierich MP et al. Human platelets attenuate Aspergillus species via granule-dependent mechanisms. J Infect Dis 2008; 198: 1243-6.
91. Lass-Flörl C, Wiedauer B, Mayr A et al. Antifungal properties of 5-hydroxytryptamine (serotonin) against Aspergillus spp. in vitro. Int J Med Microbiol 2002; 291: 655-7.
92. Perkhofer S, Niederegger H, Blum G et al. Interaction of 5-hydroxytryptamine (serotonin) against Aspergillus spp. in vitro. Int J Antimicrob Agents 2007; 29: 424-9.
93. Bozza S, Gaziano R, Spreca A et al. Dendritic cells transport conidia and hyphae of Aspergillus fumigatus from the airways to the draining lymph nodes and initiate disparate Th responses to the fungus. J Immunol 2002; 168: 1362-71.
94. Cenci E, Mencacci A, Fe d'Ostiani C et al. Cytokine- and T helper-dependet lung mucosal immunity in mice with invasive pulmonary aspergillosis. J Infect Dis 1998; 178: 1750-60.
95. Cenci E, Mencacci A, Casagrande A et al. Impaired antifungal effector activity but not inflammatory cell recruitment in interleukin-6-deficient mice with invasive pulmonary aspergillosis. J Infect Dis 2001; 184: 610-7.
96. Del Sero G, Mencacci A, Cenci E et al. Antifungal type 1 responses are upregulated in IL-10-deficient mice. Microbes Infect 1999; 1: 1169-80.
97. Bellocchio S, Montagnoli C, Bozza S et al. The contribution of the Toll-like/IL-1 receptor supefamily to innate and adaptive immunity to fungal pathogens in vivo. J Immunol 2004; 172: 3059-69.
98. Roilides E, Sein T, Roden M, Schaufele RL, Walsh TJ. Elevated serum concentrations of Interleukin-10 in non neutropenic patients with invasive aspergillosis. J Infect Dis 2001; 183: 518-20.
99. Balloy V, Chignard M. The innate immune response to Aspergillus fumigatus. Microbes Infect 2009; 11: 919-27.
100. Zelante T, De Luca A, D'Angelo C, Moretti A, Romani L. IL17/Th17 in anti-fungal immunity: what's new?Eur J Immunol 2009; 39: 645-8.
101. Hamad M. Innate and adaptive antifungal immune responses: partners on an equal footing. Mycoses 2012; 55: 205-217.
102. Zelante T, Iannitti R, De Luca A, Romani L. IL-22 in antifungal immunity. Eur J Immunol 2011; 41: 270-5.
103. Chamilos G, Ganguly D, Lande R et al. Generation of IL-23 producing dendritic cells (dCs) by airborne fungi regulates fungal pathogenicity via the induction of T(H)-17 responses. PLoS ONE 2010; 5: e12955.
104. Chai LY, van de Veerdonk F, Marijnissen RJ et al. Anti-Aspergillus human host defence relies on type 1 T helper (Th1), rather than type 17 T helper (Th17), cellular immunity. Immunol 2010; 130: 46-54.